Alumis is seeking an experienced Executive Medical Director or Senior Medical Director to lead clinical development strategy and execution for Phase 1 and Phase 2 studies in neurology and additional new indications. A centerpiece of this role is A-005, Alumis's CNS-penetrant TYK2 inhibitor with potential in neuroinflammatory and neurodegenerative diseases - a first-mover opportunity to bring a differentiated mechanism to patients with devastating neurological conditions. This high-impact role will shape Alumis's expanding clinical portfolio from the ground up, from indication selection and study design through proof-of-concept readout, and will serve as a key scientific leader and external face of the program with investigators, regulatory authorities, and the broader medical community.
Key ResponsibilitiesClinical Development Strategy & Leadership
- Lead the design, planning, and execution of Phase 1 and Phase 2 clinical studies for A-005 in neurology (e.g., neurodegenerative diseases, movement disorders) and for additional pipeline molecules in inflammatory and immunologic indications
- Develop and refine clinical development plans, including study synopses, protocols, and integrated development strategies for new indications
- Provide clinical and scientific leadership to cross-functional study teams, ensuring alignment on program goals, timelines, and deliverables
- Collaborate with Translational Medicine and Research teams to evaluate and prioritize new indication opportunities based on scientific rationale, competitive landscape, and unmet medical need
Study Execution & Oversight
- Serve as the Medical Monitor for assigned Phase 1 and 2 studies, ensuring patient safety and scientific integrity
- Oversee medical aspects of study conduct, including safety surveillance, protocol amendments, and data review
- Partner with Clinical Operations, Biostatistics, and Regulatory Affairs to ensure efficient study execution and high-quality data generation
- Lead interactions with Data Safety Monitoring Boards (DSMBs) and provide medical input for safety analyses
Regulatory & External Engagement
- Contribute to regulatory strategy and serve as a clinical representative in interactions with FDA and international regulatory authorities (EMA, PMDA, etc.)
- Prepare and review clinical sections of regulatory submissions, including IND amendments, briefing documents, and meeting packages
- Represent Alumis at scientific conferences, advisory boards, and with Key Opinion Leaders (KOLs) to advance clinical programs and gather external insights
- Build and maintain relationships with investigators, academic collaborators, and the broader medical community
Cross-Functional Collaboration
- Work closely with Translational Sciences, Biomarker, and Pharmacology teams to integrate biomarker strategies into clinical study designs
- Collaborate with Commercial and Medical Affairs teams on disease landscape assessments and indication prioritization
- Provide clinical expertise to support business development activities, including evaluation of potential partnerships or in-licensing opportunities
Team Development
- Mentor and develop junior medical staff, fostering a culture of scientific excellence and collaboration
- Contribute to building Alumis's clinical development capabilities as the organization grows
Required Qualifications
- MD required; neurology experience required; board certification or fellowship training in Neurology highly desired; additional experience in inflammatory disease areas (e.g., rheumatology, dermatology) a plus
- 10+ years of pharmaceutical/biotechnology industry experience in clinical development, with a significant focus on neurology; experience in immunology or autoimmune diseases a plus
- Demonstrated experience leading Phase 1 and Phase 2 clinical studies from design through data readout
- Track record of successful regulatory interactions (FDA, EMA) and experience preparing IND/CTA submissions
- Deep understanding of early clinical development, including dose-finding strategies, biomarker integration, and adaptive trial designs
- Strong scientific acumen with the ability to critically evaluate preclinical and clinical data to inform development strategy
- Experience with JAK/TYK2 inhibitors or related immunomodulatory mechanisms, preferred
- Excellent leadership, communication, and interpersonal skills with the ability to influence cross-functional teams in a matrixed environment
- Strategic mindset with demonstrated ability to balance scientific rigor with business objectives
Preferred Qualifications
- Experience with indication expansion or lifecycle management for neurology or immunology assets
- Prior experience at a small or mid-sized biotechnology company; comfort operating in a fast-paced, resource-conscious environment
- Established relationships with KOLs in neurology; relationships in rheumatology, dermatology, or other inflammatory disease areas also valued
- Experience across multiple therapeutic indications, including neurological diseases (e.g., neurodegenerative diseases, movement disorders) and/or inflammatory conditions such as psoriasis, psoriatic arthritis, lupus, or atopic dermatitis
- Familiarity with regulatory pathways for expedited development (Breakthrough Therapy, Fast Track)
What We Offer
- Opportunity to shape the clinical development strategy for a best-in-class TYK2 inhibitor portfolio
- High-visibility leadership role with direct interaction with executive leadership and the CMO
- Collaborative, science-driven culture focused on transforming patient outcomes
- Competitive compensation package including base salary, annual bonus, and equity participation
- Comprehensive benefits including health, dental, vision, 401(k), and generous PTO
Travel Requirements
Travel required (approximately 20-30%) to support investigator meetings, scientific conferences, regulatory interactions, and site visits.
This position is located in South San Francisco, CA and employees are expected to be onsite Tuesday-Thursday. Remote candidates will be considered on a case-by-case basis.
The salary range for this position is $300,000 USD to $400,000 USD annually. This salary range is an estimate, and the actual salary may vary based on the Company's compensation practices.